As cash-pay patients search for affordable compounded GLP-1 access in 2026, Direct Meds stands out for its active LegitScript certification, consistent pricing with no first-month introductory rate, and a sublingual needle-free format unavailable at most competing telehealth platforms.

The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with some downsides takes its place.

Through Amazon Pharmacy, patients will be able to access medications including Novo Nordisk's Wegovy as well as newer oral GLP-1 options.

Memberships starting at $25 per month for insured patients give eligible members nationwide access to semaglutide and tirzepatide treatment options, along with oral GLP-1 alternatives, through a streamlined telehealth platform supported by an Insurance

How Compounded Semaglutide, Compounded Tirzepatide, and GLP-1 Telehealth Prescription Weight Loss Programs Work for Eligible Adults in 2026

Starting July 2026, Medicare will pilot a program offering select GLP-1 weight loss drugs, including Wegovy, Zepbound, and Foundayo, for a flat $50 monthly copay. The 18-month 'GLP-1 Bridge' aims to expand access before a possible longer-term plan in 2028 ...

Even in a world where GLP-1 weight loss drugs seem like a miraculous weight loss solution, diet, exercise, and other healthy lifestyle changes are still needed to help people lose weight — and keep those pounds off. If you’ve struggled to make ...